Marker Therapeutics (MRKR) Receivables - Other (2013 - 2026)
Marker Therapeutics' Receivables - Other was $1.62 million in Q2 2026, down 3.3% from $1.67 million a year earlier but up 17.6% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Receivables - Other (2013 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Marker Therapeutics came in at $1.37 million, down 41.6% from FY2024.
- Receivables - Other shows a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- In earlier years, Receivables - Other was $2.35 million in FY2024 (+128.3%), $1.03 million in FY2023 (-57.2%), $2.4 million in FY2022 and $237.00 in FY2021 (-100.0%).
- Quarterly Receivables - Other has moved between $237.00 (Q4 2021) and $2.49 million (Q2 2024) over five years.
- Compared with a year earlier, Receivables - Other has declined for three straight quarters, with growth averaging 119.6% over the last eight quarters.
- The best year-over-year quarter for Receivables - Other over five years was Q3 2024 (growth of 793.5%); the worst was Q4 2021 (a decline of 100.0%).
- Per Business Quant data, MRKR's Receivables - Other in the three quarters before Q2 2026 was $1.38 million (Q1 2026), $1.37 million (Q4 2025) and $1.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 744,410.00 |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 83,313.00 |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 627,629.00 |
| Mar 31, 2022 | 2,185.00 |
| Dec 31, 2021 | 237.00 |
| Sep 30, 2021 | 243.00 |
API Access
Marker Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();